Thrombolytic therapy in thrombocytopenic patients

Robert A. Harrington, David C. Sane, Robert M. Califf, Kristina N. Sigmon, Charles W. Abbottsmith, Richard J. Candela, Kerry L Lee, Eric J. Topol, Clinical importance of thrombocytopenia occurring in the hospital phase after administration of thrombolytic therapy for acute myocardial infarction Journal of the American College of Cardiology. ,vol. 23, pp. 891- 898 ,(1994) , 10.1016/0735-1097(94)90634-3

Jeffrey I. Cohen, Streptokinase Therapy of Pulmonary Emboli With Heparin-Associated Thrombocytopenia Archives of Internal Medicine. ,vol. 145, pp. 1725- 1726 ,(1985) , 10.1001/ARCHINTE.1985.00360090201031

John A. Dieck, Carlos Rizo-Patron, A. Unisa, Virendra Mathur, G. Ali Massumi, A New Manifestation and Treatment Alternative for Heparin-Induced Thrombosis Chest. ,vol. 98, pp. 1524- 1526 ,(1990) , 10.1378/CHEST.98.6.1524

C. R. Conti, Is menstruation a contraindication to thrombolytic therapy? Clinical Cardiology. ,vol. 15, pp. 625- 626 ,(1992) , 10.1002/CLC.4960150902

T Kwan, P Hansard, Recombinant tissue-plasminogen activator for acute Budd-Chiari syndrome secondary to paroxysmal nocturnal hemoglobinuria. New York state journal of medicine. ,vol. 92, pp. 109- 110 ,(1992)